Carcinoembryonic antigen (CEA)

Reference

Reference
Coşkun A, Aarsand AK, Sandberg S, Guerra E, Locatelli M, Díaz-Garzón J, Fernandez-Calle P, Ceriotti F, Jonker N, Bartlett WA, Carobene A, 2021, Clin Chem Lab Med, Online ahead of print, , Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study

Scoring

Total Score

A1,2,3,4,5,6,7,8,9,10,11,12,13,14

Parameter Score
1. Scale A
2. Study Population A
3. Samples A
4. Measurand A
5. Pre-Analytical A
6. Replicate Analysis A
7. Steady State A
8. Outlier Analysis A
9. Normality A
10. Variance Homogeneity A
11. ANOVA A
12. CI A
13. No of Results A
14. Concentrations A
15. Total Score A1,2,3,4,5,6,7,8,9,10,11,12,13,14
Comment

Item Details

Parameter Score
Matrix Serum
Measurand Carcinoembryonic antigen (CEA)
Unit ug / L
Overall Analytical Principle Method Immunoassay; Not specified
Number of Subjects 9
Number of Subjects included in BV estimation 9
Ethinicity Caucasian
Age Mean / Median
Age Min 21.0
Age Max 69.0
Age SD
Number of Males
Number of Females 9
State of Well Being
Healthy (excl pregnant)
Diseases
Study Duration Length 10
Study Duration Units Week
Sampling Intervals, e.g. X sample(s) per Interval Unit 1
Interval Units Week
Sampling Times Start Time: 08:00
End Time: 10:00
Number of Samples 10
Average Number of Samples Used for BV Estimation 10.0
Average Number of Replicates 2.0
Estimates of CVi 7.2
Calculated Confidence Intervals of CVi Lower: 6.20, Upper: 8.56
Estimates of CVg 41.2
Calculated Confidence Intervals of CVg Lower: 28.29, Upper: 75.30
Analytical CV 2.0
Calculated Confidence Intervals of Analytical CV Lower: 1.75, Upper: 2.34
Measurand Mean 2.0
Measurand Min 1.8
Measurand Max 2.1
Measurand SD

Coding